The Central Drugs Standard Control Organisation has ordered an investigation into the popular anti-acidity drug Ranitidine for possible presence of an impurity, which may cause cancer.
This was done after a US drug regulator found N-nitrosodimethylamine (NDMA) in some products containing Ranitidine.
The order was taken after one of the many drug majors, Dr Reddy’s, pulled many versions of the product off the shelves, reports The Economic Times.
The panel will examine close to 180 brands of Ranitidine sold in the country.
The drug, that is used for stomach acidity in treatment of intestinal ulcers, esophagitis, Zollinger-Ellison syndrome and other diseases, will be recalled for precautionary reasons by international regulators including USFDA and EMA.
Twitter was curious and netizens had their warning beacons on.
Safe to say, be 100% sure before consuming one of the many available types of Ranitidine medicine.